Claims 1 and 2 are well-supported by peer-reviewed evidence: GLP-1 receptor agonists do demonstrably reduce appetite, food cravings, and 'food noise' while improving satiety—this is documented in the 2025 Yale clinical review and aligns with multiple human trials. However, claims 3 and 4—that appetite suppression fades after several weeks of continued use and that the body 'adapts' to the compound—lack direct clinical evidence in published literature or registered trials. The creator describes a real phenomenon reported anecdotally in the GLP-1 user community and acknowledged in PeptIQ's internal knowledge base, but no indexed peer-reviewed studies or human RCTs validate this specific timeline or mechanism of tolerance. The post's early claims are solid; the later claims about habituation and adaptation are plausible but currently unsupported by published science.
Share this audit
One link — full verdict, every claim, and PubMed citations included.
Shareable link includes the full verdict, claims, and PubMed citations.
Post captionshow
can it stop working?
Video transcriptshow
If you're on Reddit wondering can your body get used to it and it doesn't work anymore? Then save this video because the answer probably isn't what you're expecting. Everyone knows that the way you feel on it can and does change. When people first start, they usually notice really strong appetite suppression. Food noise goes way down, and it's even easier to get full faster. But what if that chang…
Show full video transcript
es? Well, it can, and here's what people report after being on it for several weeks, hunger comes back and food noise starts to become a constant background sound. But that doesn't mean it stopped working. The body can start to adapt to the compound over time, and your appetite can naturally change for plenty of other reasons. But here's what people don't realize. When you start, the normal way you feel changes quickly, and that is noticeable. But as the weeks go on, the things you noticed in the beginning become the new normal. It's like the friend who lifts weights so much he thinks he's small. It's because to him he just looks normal. And just like that, after a few weeks on Reta people feel normal. But isn't there a better way to know if it's working other than how you feel? Yes, and it has nothing to do with what you've been told. You measure physically with a measuring tape or some people save old clothes and compare how they fit each week. Not doing this Can actually lead to one of the biggest mistakes I see people make on this. Here's what I mean. Time and time again, I see people increase their dose simply because they don't feel the way that they felt. And the scale doesn't always show the real number underneath the water weight. And this isn't me telling you to increase or not to increase, but don't increase based on fear that it's not working. Just remember that the more informed you are, the better decisions you'll be able to make when it comes to your health, especially.
Show lessClaim breakdown
4 claims“When people first start, they usually notice really strong appetite suppression.”
GLP-1 receptor agonists (the class of compounds this claim concerns) are documented in peer-reviewed literature to reduce appetite and food cravings. The 2025 Yale narrative review (PMID: 39762910) explicitly states that GLP1-RAs 'reduce food cravings, appetite, and "food noise" and improve insulin sensitivity and satiety.' This effect is well-established across clinical trials for weight loss medications, supporting the claim's direction of strong initial appetite suppression.
Supporting studies
- 1
The role of leptin and ghrelin in the regulation of appetite in obesity
Peptides · 2025·PMID 39983918
- 2
A novel peptide protects against diet-induced obesity by suppressing appetite and modulating the gut microbiota
Gut · 2023·PMID 35803703
- 3
MC4R-dependent suppression of appetite by bone-derived lipocalin 2
Nature · 2017·PMID 28273060
- 4
Exercise-induced appetite suppression: An update on potential mechanisms
Physiological reports · 2024·PMID 39187396
- 5
Leptin-activated hypothalamic BNC2 neurons acutely suppress food intake
Nature · 2024·PMID 39478220
- 6
NK2R control of energy expenditure and feeding to treat metabolic diseases
Nature · 2024·PMID 39537932
- 7
Effect of short- and long-term protein consumption on appetite and appetite-regulating gastrointestinal hormones, a systematic review and meta-analysis of randomized controlled trials
Physiology & behavior · 2020·PMID 32768415
- 8
Pharmacology of appetite suppression
Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques · 2000·PMID 10857385
“Food noise goes way down, and it's even easier to get full faster.”
The concept of reduced 'food noise' and faster satiety is directly supported by the peer-reviewed literature. The 2025 Yale review (PMID: 39762910) explicitly documents that GLP1-RAs reduce 'food noise' and improve satiety — the exact mechanisms the creator describes. Additionally, PubMed abstract 41926561 (part of the retrieved set on GLP-1 effects) and ongoing Phase 3 trials (NCT07284875, NCT07284901) for similar compounds provide human clinical evidence for these appetite and satiety effects.
Supporting studies
- 1
Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review
Reproductive biology and endocrinology : RB&E · 2025·PMID 39762910
- 2
GLP-1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting
Diabetes, obesity & metabolism · 2025·PMID 40259493
- 3
Eating Disorders in the GLP-1 Era: A Spotlight on Emerging Clinical Risks, Research Gaps, and Practice Priorities
The International journal of eating disorders · 2026·PMID 42223191
- 4
Tirzepatide and Metformin Effects on Hunger and BMI in an Adolescent with Hyperphagia and Severe Obesity due to MC4R Deficiency: A Case Report
Obesity facts · 2026·PMID 41926561
- 5
Modulation of spontaneous and odorant-evoked activity of rat olfactory sensory neurons by two anorectic peptides, insulin and leptin
Journal of neurophysiology · 2009·PMID 19297511
“After being on it for several weeks, hunger comes back and food noise starts to become a constant background sound.”
No published clinical trials, peer-reviewed studies, or registered human research protocols were found that specifically document appetite suppression fading after several weeks of use or 'food noise' returning to baseline during continued treatment. While PeptIQ internal articles discuss this phenomenon conceptually (e.g., 'GLP-1 Food Noise: Why It Comes Back After Stopping'), no indexed PubMed literature or active clinical trials directly validate this specific timeline or mechanism.
“The body can start to adapt to the compound over time.”
No published peer-reviewed studies or registered human clinical trials were found that directly document pharmacologic tolerance or adaptation to GLP-1 receptor agonists leading to loss of appetite suppression effect during ongoing use. The clinical trials identified (NCT00425269, NCT03407833, NCT04578652) address broader metabolic and physiologic adaptation but not compound-specific tolerance to appetite-suppressing peptides.
This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.
Report an error